PharmaTher Holdings Ltd(PHRRF)
$0.04+0.00 (+2.70%)
PHRRF
PharmaTher Holdings Ltd financials statements
$0.04
At close:+0.00 (+2.70%)
PharmaTher Holdings Ltd (PHRRF) Ratios
50 Followers
PharmaTher Holdings Ltd Ratios
PHRRF's free cash flow for Q4 2026 was C$-106.60K. For the 2026 fiscal year, PHRRF's free cash flow was increased by C$0.00 and operating cash flow was C$-106.60K. See a summary of the company’s cash flow.
| Ratios | Aug 26 | Aug 25 | Aug 24 | Aug 23 | Aug 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.83 | 3.11 | 9.25 | 7.07 | 36.82 |
| Quick Ratio | 1.83 | 3.11 | 9.25 | 7.07 | 36.82 |
| Cash Ratio | 1.35 | 2.52 | 8.44 | 6.63 | 27.72 |
| Solvency Ratio | -1.20 | -4.16 | -12.32 | -7.19 | -12.14 |
| Operating Cash Flow Ratio | -0.95 | -3.30 | -13.92 | -3.62 | -10.63 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | C$ 420.29K | C$ 772.81K | C$ 2.09M | C$ 5.42M | C$ 11.83M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.83 | 1.38 | 1.11 | 1.16 | 1.03 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.81 | 0.61 | 0.70 | 1.50 | 2.31 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 94.69% |
| EBT Per EBIT | 72.16% | 100.16% | 102.34% | 162.03% | 103.25% |
| Return on Assets (ROA) | -54.39% | -113.90% | -120.29% | -101.69% | -32.97% |
| Return on Equity (ROE) | -99.56% | -156.76% | -133.31% | -118.44% | -33.89% |
| Return on Capital Employed (ROCE) | -137.98% | -156.50% | -130.26% | -73.10% | -34.67% |
| Return on Invested Capital (ROIC) | -137.98% | -156.50% | -128.22% | -73.10% | -32.83% |
| Return on Tangible Assets | -54.39% | -113.90% | -120.29% | -101.69% | -32.97% |
| Earnings Yield | -11.18% | -9.52% | -17.66% | -66.16% | -32.97% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -25.46 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -125321.29 | -226193.44 | -65831.05 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | -14.34 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 125321.29 | 226179.10 | 65831.05 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | -14.34 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.02 | -0.04 | -0.04 | -0.04 |
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.04 | -0.04 | -0.04 |
| Dividend Paid and CapEx Coverage Ratio | -161669.00 | 0.00 | -1173859.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -161669.00 | 0.00 | -1173859.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -8.88% | -7.55% | -19.96% | -33.36% | -28.86% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.96 | -12.21 | -5.66 | -1.51 | -3.03 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 8.91 | 16.46 | 7.55 | 1.79 | 1.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -11.26 | -13.24 | -5.01 | -3.00 | -3.47 |
| Price-to-Operating Cash Flow Ratio | -11.26 | -13.24 | -5.01 | -3.00 | -3.47 |
| Price-to-Earnings Growth (PEG) Ratio | 0.15 | 0.24 | 0.11 | -0.03 | 0.01 |
| Enterprise Value Multiple | -5.64 | -9.92 | -5.10 | -0.95 | -0.76 |
| Enterprise Value | 4.77M | 15.10M | 15.51M | 3.78M | 3.01M |
| EV to EBITDA | -5.64 | -9.92 | -5.10 | -0.95 | -0.76 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -9.84 | -12.48 | -4.40 | -1.17 | -0.86 |
| EV to Operating Cash Flow | -9.84 | -12.48 | -4.40 | -1.17 | -0.86 |
| Tangible Book Value Per Share | 0.01 | 0.01 | 0.03 | 0.06 | 0.15 |
| Shareholders’ Equity Per Share | 0.01 | 0.01 | 0.03 | 0.06 | 0.15 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.02 | -0.38 | 0.05 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.02 | -0.04 | -0.07 | -0.05 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.95 |
| Interest Burden | 0.72 | 1.00 | 1.02 | 1.62 | 1.07 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.79 | 0.79 | 1.13 | 0.50 | 0.88 |
Currency in CAD
